Addus HomeCare Corporation ADUS

A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.

When examining a long-term compounder, astute market participants look past quarterly headlines to evaluate core operational drivers, margin stability, and pricing power. Addus HomeCare (NASDAQ:ADUS) embodies many classic characteristics of a durable portfolio holding: a sticky, non-franchise personal care delivery model, consistent organic growth, and a disciplined approach to capital allocation across fragmented regional markets. […]

Addus HomeCare (ADUS) heads into its 2026 Jefferies Healthcare Services and Technology Conference appearance with fresh attention on its AccentCare personal care acquisition and the stock’s recent sector driven move. After a strong run that produced a 23.45% 90 day share price return and lifted year to date share price gains to 8.73%, Addus HomeCare has seen momentum cool slightly in the last week as investors weigh the AccentCare deal, evolving Medicaid headlines, and the stock’s longer term...

Addus HomeCare' (ADUS) $275 million acquisition of AccentCare's personal care division will likely s

Healthcare stocks advanced late Monday afternoon, with the NYSE Healthcare Index up 1.5% and the Sta

Addus HomeCare (ADUS) agreed to acquire AccentCare's personal care operations outside of New York in

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.

Addus HomeCare's (ADUS) exposure to Medicaid funding pressures is expected to be offset by potential

FRISCO, Texas, September 14, 2026--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, today announced a definitive agreement to acquire the personal care division of AccentCare for an anticipated purchase price, after customary purchase price adjustments, of approximately $275.0 million. The transaction relates only to AccentCare’s personal care operations outside of New York and does not relate to its hospice and home health operations. The acquired operations serve an

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies — as Jeff Bezos said, “Your margin is my opportunity”.

FRISCO, Texas, September 08, 2026--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, today announced that Brian Poff, Executive Vice President and Chief Financial Officer, and Brad Bickham, Chief Operating Officer on an Interim Basis, will participate in the 2026 Jefferies Healthcare Services and Technology Conference, September 14 - 15, 2026, in Nashville, Tennessee.

Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 will surely remember that the market’s punishment can be swift and severe when trajectories fall.

Its deepest fall inside a market shock is not its deepest fall, and that gap is what a holder should size for.

Addus HomeCare Q2 results and what they mean for the stock Addus HomeCare (ADUS) drew attention after reporting Q2 2026 results that showed revenue in line with expectations alongside an earnings per share beat. For investors, that mix raises fresh questions about how the stock reflects its fundamentals. The share price of Addus HomeCare has eased slightly in the short term, with the 1-day, 7-day and 30-day share price returns all down modestly, even after a strong 90-day share price return...

Addus HomeCare stock has delivered a 34.6% gain over the past three years, while a fresh intrinsic value estimate suggests the current price may still sit below what its future cash flows imply. The market price near US$118 puts investors between a strong historical return and an analytical view that points to possible undervaluation. A 34.6% share price gain over three years shows that Addus HomeCare has already rewarded patient investors, so the question is how much of the long term...